Literature DB >> 6199368

Production of Vibrio cholerae O1 and non-O1 typing sera in rabbits immunized with polysaccharide-protein carrier conjugates.

L B Adams, R J Siebeling.   

Abstract

Two systems are currently used to serologically type Vibrio cholerae O1 and non-O1 isolates. Antiserovar-serotype serum in the Smith system is produced in rabbits immunized with live whole-cell vaccines, and that in the Sakazaki system is produced in rabbits immunized with heat-killed vaccines. In neither system is the serovar-serotype-specific antigen clearly defined. During the course of a serological survey, ca. 10% of more than 2,500 V. cholerae isolates examined agglutinated in the optimal dilutions of two, three, or four different anti-serovar sera prepared by the methods of Sakazaki. An occasional isolate agglutinated in both anti-O1 and non-O1 sera. Lipopolysaccharide was extracted from eight of these possible multiple serovars, coated onto rabbit erythrocytes, and retested in these same antisera by passive hemagglutination. With one exception the lipopolysaccharide-rabbit erythrocytes were now agglutinated in a single antiserum. Antipolysaccharide sera were produced in rabbits immunized with the polysaccharide moiety extracted from eight non-O1 and two O1 vaccine strains conjugated to bovine gamma globulin protein carrier. The antipolysaccharide sera showed passive hemagglutination titers versus lipopolysaccharide-rabbit erythrocytes comparable to those achieved in antisera from rabbits immunized with heat-killed whole-cell vaccines. In the slide agglutination test antipolysaccharide sera serologically discriminated between two O1 isolates that were previously agglutinated in both anti-O1 and anti-non-O1 whole-cell sera. It is recommended that serological types or varieties of V. cholerae non-O1 be based upon serologically recognizable differences in lipopolysaccharide-associated antigens as are antigens A, B, and C in the O1 group.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199368      PMCID: PMC271013          DOI: 10.1128/jcm.19.2.181-186.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Serological studies on the cholera group of vibrios.

Authors:  R Sakazaki; K Tamura; C Z Gomez; R Sen
Journal:  Jpn J Med Sci Biol       Date:  1970-02

2.  Additional serovars and inter-O antigenic relationships of Vibrio cholerae.

Authors:  T Shimada; R Sakazaki
Journal:  Jpn J Med Sci Biol       Date:  1977-10

3.  Serovars of Vibrio cholerae identified during 1970-1975.

Authors:  R Sakazaki; T Shimada
Journal:  Jpn J Med Sci Biol       Date:  1977-10

4.  Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast.

Authors:  J B Kaper; H B Bradford; N C Roberts; S Falkow
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

5.  The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba).

Authors:  J W Redmond
Journal:  Biochim Biophys Acta       Date:  1979-05-01

6.  Serological comparison of two collections of Vibrio cholerae non O1.

Authors:  D J Brenner; B R Davis; Y Kudoh; M Ohashi; R Sakazaki; T Shimada; H L Smith
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

  6 in total
  10 in total

1.  Isolation of Non-O1 Vibrio cholerae Serovars from Oregon Coastal Environments.

Authors:  D L Tison; M Nishibuchi; R J Seidler; R J Siebeling
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

2.  Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region.

Authors:  J B Kaper; J P Nataro; N C Roberts; R J Siebeling; H B Bradford
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

3.  Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.

Authors:  L B Adams; M C Henk; R J Siebeling
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

4.  Identification of Vibrio vulnificus O serovars with antilipopolysaccharide monoclonal antibody.

Authors:  S J Martin; R J Siebeling
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

5.  A novel kit for rapid detection of Vibrio cholerae O1.

Authors:  J A Hasan; A Huq; M L Tamplin; R J Siebeling; R R Colwell
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

6.  Ecology of Vibrio cholerae non-O1 and Salmonella spp. and role of zooplankton in their seasonal distribution in Fukuyama coastal waters, Japan.

Authors:  K Venkateswaran; T Takai; I M Navarro; H Nakano; H Hashimoto; R J Siebeling
Journal:  Appl Environ Microbiol       Date:  1989-06       Impact factor: 4.792

7.  Development of monoclonal antibodies that identify Vibrio species commonly isolated from infections of humans, fish, and shellfish.

Authors:  D Chen; P J Hanna; K Altmann; A Smith; P Moon; L S Hammond
Journal:  Appl Environ Microbiol       Date:  1992-11       Impact factor: 4.792

8.  Monoclonal antibodies to Vibrio cholerae O1 serotype inaba.

Authors:  T Ito; T Yokota
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

9.  Application of ribotyping for differentiating Vibrio cholerae non-O1 isolated from shrimp farms in Thailand.

Authors:  A Dalsgaard; P Echeverria; J L Larsen; R Siebeling; O Serichantalergs; H H Huss
Journal:  Appl Environ Microbiol       Date:  1995-01       Impact factor: 4.792

10.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.